Clinical Trial Update: Pre-meal Protein Drink Improve Glycemic Regulation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating a pre-meal protein drink to improve glycemic regulation in Type 2 Diabetes Mellitus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Pre-meal Protein Drink

Snippet

Sponsor: Lund University | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: TERMINATED